Clinical trial

Physiological Effects of Grape Seed Extract in Diastolic Heart Failure

NCT01185067

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE1

Study timeline

Study start (actual)2010-10-01Date precision: month

Registry last updated2017-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diastolic Heart Failureunresolved

Hypertensive Heart Diseaseunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Hypertensionunresolved

Oxidative Stressunresolved

Interventions

grape seed extract (MegaNatural BP, Polyphenolics, Inc.)DRUG

Sponsors & collaborators

University of Michiganlead sponsor

Mapped research locations

Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01185067 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.